The Clorox Company
CLX
$117.61
-$0.16-0.14%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.77% | -18.90% | 4.47% | -8.05% | -15.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.77% | -18.90% | 4.47% | -8.05% | -15.28% |
| Cost of Revenue | 0.11% | -12.87% | 4.01% | -11.56% | -14.80% |
| Gross Profit | -1.90% | -26.05% | 5.00% | -3.26% | -15.89% |
| SG&A Expenses | -3.21% | -8.07% | -15.19% | -5.54% | -5.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 50.00% | 600.00% | -50.00% | -175.00% | -55.56% |
| Total Operating Expenses | -0.96% | -10.82% | -3.08% | -10.14% | -12.00% |
| Operating Income | 0.43% | -59.39% | 47.87% | 6.64% | -31.18% |
| Income Before Tax | -9.28% | -39.55% | 49.09% | 704.76% | 74.26% |
| Income Tax Expenses | 25.58% | -66.22% | 37.04% | 687.50% | 7.50% |
| Earnings from Continuing Operations | -17.01% | -20.39% | 52.04% | 482.00% | 102.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -300.00% | 50.00% | 20.00% | -400.00% | 66.67% |
| Net Income | -18.65% | -19.19% | 53.70% | 464.71% | 107.53% |
| EBIT | 0.43% | -59.39% | 47.87% | 6.64% | -31.18% |
| EBITDA | 1.05% | -49.57% | 41.09% | 4.23% | -27.71% |
| EPS Basic | -17.21% | -18.42% | 55.11% | 467.28% | 108.23% |
| Normalized Basic EPS | -1.01% | -64.50% | 54.37% | 3.94% | -29.82% |
| EPS Diluted | -16.82% | -18.72% | 55.54% | 465.41% | 106.73% |
| Normalized Diluted EPS | -0.56% | -64.37% | 54.58% | 3.35% | -30.07% |
| Average Basic Shares Outstanding | -1.75% | -0.94% | -0.91% | -0.71% | -0.33% |
| Average Diluted Shares Outstanding | -2.20% | -1.33% | -1.05% | -0.15% | 0.03% |
| Dividend Per Share | -- | 1.64% | 1.64% | 1.67% | 1.67% |
| Payout Ratio | 0.23% | 0.24% | -0.35% | 1.28% | -0.51% |